Patent directory · USPTO A61K / A61P
Patents matching “Regents of the University of CA”
3,501 pharma patents match "Regents of the University of CA" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 3,501 pharmaceutical patents matching "Regents of the University of CA" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
US 7132403
Antihelminthic anthraquinones and method of use thereof
granted -
US 7132271
Methods for enhancing the production of viral vaccines in cell culture
granted -
US 7132454
HEXIM1 as a suppressor of HIV replication and cardiac hypertrophy
granted -
US 7132122
Direct micro-patterning of lipid bilayers using UV light and selected uses thereof
granted -
US 7128895
Use of bile acid derivatives conjugated with metal ion chelated complexes for the diagnostic assessment of microvascular permeability
granted -
US 7125969
ETS-related gene overexpressed in human breast and epithelial cancers
granted -
US 7125857
Modulators of DNA cytosine-5 methyltransferase and methods for use thereof
granted -
US 7125965
MRI probes of membrane potential
granted -
US 7122579
Eye treatments using synthetic thyroid hormone compositions
granted -
US 7122714
Mouse models of human prostate cancer
granted -
US 7119223
Interleukin-1 and tumor necrosis factor-α modulators, synthesis of said modulators and their enantiomers and methods of using said modulators
granted -
US 7119105
Methods for treating neurodegenerative disorders using aspartyl protease inhibitors
granted -
US 7115560
Methods for modulating gastric secretion using prokineticin receptor antagonists
granted -
US 7115582
HoxD3 and HoxA3 compositions and methods for improved wound healing
granted -
US 7112338
Cationic liposome delivery of taxanes to angiogenic blood vessels
granted -
US 7112566
Systemic administration of Hypocretin-1
granted -
US 7108986
Glypican-1 in human breast cancer
granted -
US 7105560
Use of etodolac in the treatment of multiple myeloma
granted -
US 7105561
Use of etodolac for the treatment of prostate cancer
granted -
US 7105171
Porin B (PorB) as a therapeutic target for prevention and treatment of infection by Chlamydia
granted -
US 7105330
Human plasma hyaluronidase
granted -
US 7105156
Method of using an adenoviral vector encoding a retinoblastoma protein to treat hyperproliferating cells
granted -
US 7105183
Chlorite in the treatment of neurodegenerative disease
granted -
US 7105641
MCP-1 receptor antibodies
granted